Amgen Inc. Earnings

Amgen Inc.’s revenue jumped 8.91% since last year same period to $9896Mn in the Q4 2025. On a quarterly growth basis, Amgen Inc. has generated 3.55% jump in its revenue since last 3-months.

Amgen Inc.’s net profit jumped 112.6% since last year same period to $1333Mn in the Q4 2025. On a quarterly growth basis, Amgen Inc. has generated -58.55% fall in its net profits since last 3-months.

Amgen Inc.’s net profit margin jumped 95.2% since last year same period to 13.47% in the Q4 2025. On a quarterly growth basis, Amgen Inc. has generated -59.97% fall in its net profit margins since last 3-months.

Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 5.16 - a 9.32% jump from last quarter’s estimates.

Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 5.16.

Amgen Inc.’s earning per share (EPS) fell -0.38% since last year same period to 5.29 in the Q4 2025. This indicates that the Amgen Inc. has generated -0.38% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Amgen Inc. declared 2.38 dividend per share during the earnings announcement for Q4 2025.